Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat protein 29 (TTC29) is an axonemal protein containing tetratricopeptide repeats, which are protein-protein interaction motifs known for mediating the assembly of multiprotein complexes[1]. TTC29 is involved in the structure, organization, and movement of cilia, specifically in the regulation of flagellum assembly and motility in sperm. Its biological role is critical for normal sperm function, and mutations or defects in TTC29 have been associated with male infertility, primarily spermatogenic failure and sperm motility disorders[2][3][5][6]. TTC29 is not currently established as a drug target and has no documented pharmacological interactors or associated safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat protein 29 (TTC29).